This is a Validated Antibody Database (VAD) review about rat Cdc25a, based on 19 published articles (read how Labome selects the articles), using Cdc25a antibody in all methods. It is aimed to help Labome visitors find the most suited Cdc25a antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Santa Cruz Biotechnology
mouse monoclonal (F-6)
  • western blot; human; loading ...; fig 3s2d, 3g
Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz, sc-7389) was used in western blot on human samples (fig 3s2d, 3g). elife (2020) ncbi
mouse monoclonal (3H2016)
  • immunoprecipitation; human; loading ...; fig 3d
  • western blot; human; loading ...; fig 1f
Santa Cruz Biotechnology Cdc25a antibody (SantaCruz, sc-70823) was used in immunoprecipitation on human samples (fig 3d) and in western blot on human samples (fig 1f). J Virol (2018) ncbi
mouse monoclonal (F-6)
  • western blot; mouse; 1:200; loading ...; fig 5b
In order to study the role of microRNAs in the cell cycle and differentiation, Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz Biotechnology, sc-7389) was used in western blot on mouse samples at 1:200 (fig 5b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (F-6)
  • western blot; human; loading ...; fig 1d
Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz, sc-7389) was used in western blot on human samples (fig 1d). Sci Signal (2017) ncbi
mouse monoclonal (DCS 121)
  • western blot; human; loading ...; fig 6
Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz Biotechnology Inc., sc-56263) was used in western blot on human samples (fig 6). Drug Des Devel Ther (2016) ncbi
mouse monoclonal (F-6)
  • western blot; human; loading ...; fig 1b
Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz, sc-7389) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
mouse monoclonal (F-6)
  • western blot; human; 1:500; loading ...; fig 2c
In order to elucidate the upstream mechanisms of apoptosis triggered by an anti-microtubule drug, ABT-751, Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz Biotechnology, sc-7389) was used in western blot on human samples at 1:500 (fig 2c). Toxicol Appl Pharmacol (2016) ncbi
mouse monoclonal (DCS-120)
  • immunocytochemistry; human; fig 2
Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz, sc-56264) was used in immunocytochemistry on human samples (fig 2). Lipids Health Dis (2016) ncbi
mouse monoclonal (F-6)
  • western blot; mouse; 1:250; fig 3
Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz, sc-7389) was used in western blot on mouse samples at 1:250 (fig 3). Nat Commun (2016) ncbi
mouse monoclonal (F-6)
  • western blot; human; 1:1000; fig 6
Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz, sc-7389) was used in western blot on human samples at 1:1000 (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (F-6)
  • western blot; human; fig 1
In order to analyze G2 checkpoint regulators for hypoxia-induced alterations, Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz, sc-7389) was used in western blot on human samples (fig 1). Mol Oncol (2016) ncbi
mouse monoclonal (DCS-120)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology Cdc25a antibody (SCBT, DCS-120) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (F-6)
  • western blot; human; fig 3
In order to characterize LY2606368, a novel CHK1 inhibitor, Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz, SC-7389) was used in western blot on human samples (fig 3). Mol Cancer Ther (2015) ncbi
mouse monoclonal (F-6)
  • western blot; human; 1:500; fig 1
In order to report how Cep68 regulates centriole disengagement, Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz, F6) was used in western blot on human samples at 1:500 (fig 1). Nat Cell Biol (2015) ncbi
mouse monoclonal (F-6)
  • western blot; human; 1:200
Santa Cruz Biotechnology Cdc25a antibody (Santa Cruz Biotechnology, sc-7389) was used in western blot on human samples at 1:200. Biochim Biophys Acta (2014) ncbi
mouse monoclonal (F-6)
  • western blot; chicken; fig 2
Santa Cruz Biotechnology Cdc25a antibody (Santa, sc-7389) was used in western blot on chicken samples (fig 2). Nucleic Acids Res (2014) ncbi
Invitrogen
mouse monoclonal (DCS-120)
  • western blot; human; 1:1000; loading ...; fig s2
Invitrogen Cdc25a antibody (Thermo Fisher, MA5-13794) was used in western blot on human samples at 1:1000 (fig s2). Front Oncol (2021) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; human; 1:200; loading ...; fig 2a,2b
Abcam Cdc25a antibody (Abcam, ab79252) was used in western blot on human samples at 1:200 (fig 2a,2b). Nat Commun (2017) ncbi
mouse monoclonal (DCS-120 + DCS-121)
  • western blot; human
Abcam Cdc25a antibody (Abcam, ab2357) was used in western blot on human samples . Mol Biol Cell (2011) ncbi
Articles Reviewed
  1. Zhao N, Wang F, Ahmed S, Liu K, Cathcart S, Dimaio D, et al. Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma. Front Oncol. 2021;11:616625 pubmed publisher
  2. Brunner A, Suryo Rahmanto A, Johansson H, Franco M, Viiliäinen J, Gazi M, et al. PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer. elife. 2020;9: pubmed publisher
  3. Qi D, Hu L, Jiao T, Zhang T, Tong X, Ye X. Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity. J Virol. 2018;92: pubmed publisher
  4. Otto T, Candido S, Pilarz M, Sicinska E, Bronson R, Bowden M, et al. Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit. Proc Natl Acad Sci U S A. 2017;114:10660-10665 pubmed publisher
  5. Xu X, Fan Z, Liang C, Li L, Wang L, Liang Y, et al. A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity. Nat Commun. 2017;8:14059 pubmed publisher
  6. Shimizu K, Fukushima H, Ogura K, Lien E, Nihira N, Zhang J, et al. The SCF?-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis. Sci Signal. 2017;10: pubmed publisher
  7. Lv M, Li Y, Tian X, Dai S, Sun J, Jin G, et al. Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis. Drug Des Devel Ther. 2016;10:3737-3746 pubmed
  8. Bridges K, Chen X, Liu H, Rock C, Buchholz T, Shumway S, et al. MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Oncotarget. 2016;7:71660-71672 pubmed publisher
  9. Wei R, Lin S, Wu W, Chen L, Li C, Chen H, et al. A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells. Toxicol Appl Pharmacol. 2016;311:88-98 pubmed publisher
  10. Cizkova K, Steigerova J, Gursky J, Ehrmann J. Stimulating effect of normal-dosing of fibrates on cell proliferation: word of warning. Lipids Health Dis. 2016;15:164 pubmed
  11. Brosh R, Hrynyk I, Shen J, Waghray A, Zheng N, Lemischka I. A dual molecular analogue tuner for dissecting protein function in mammalian cells. Nat Commun. 2016;7:11742 pubmed publisher
  12. Soriano A, París Coderch L, Jubierre L, Martínez A, Zhou X, Piskareva O, et al. MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes. Oncotarget. 2016;7:9271-87 pubmed publisher
  13. Hasvold G, Lund Andersen C, Lando M, Patzke S, Hauge S, Suo Z, et al. Hypoxia-induced alterations of G2 checkpoint regulators. Mol Oncol. 2016;10:764-73 pubmed publisher
  14. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  15. King C, Diaz H, McNeely S, Barnard D, Dempsey J, Blosser W, et al. LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. Mol Cancer Ther. 2015;14:2004-13 pubmed publisher
  16. Pagan J, Marzio A, Jones M, Saraf A, Jallepalli P, Florens L, et al. Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM to allow centriole separation, disengagement and licensing. Nat Cell Biol. 2015;17:31-43 pubmed publisher
  17. Qiu W, Kassem M. miR-141-3p inhibits human stromal (mesenchymal) stem cell proliferation and differentiation. Biochim Biophys Acta. 2014;1843:2114-21 pubmed publisher
  18. Frankenberger S, Davari K, Fischer Burkart S, Böttcher K, Tomi N, Zimber Strobl U, et al. Checkpoint kinase 1 negatively regulates somatic hypermutation. Nucleic Acids Res. 2014;42:3666-74 pubmed publisher
  19. Sims J, Wade P. Mi-2/NuRD complex function is required for normal S phase progression and assembly of pericentric heterochromatin. Mol Biol Cell. 2011;22:3094-102 pubmed publisher